| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DORM | Common Stock | Options Exercise | $179,612 | +2,912 | +24% | $61.68 | 15,139 | 03 Dec 2024 | Direct | |
| transaction | DORM | Common Stock | Sale | $284,108 | -2,042 | -13% | $139.13 | 13,097 | 03 Dec 2024 | Direct | F1 |
| transaction | DORM | Common Stock | Sale | $121,730 | -870 | -6.6% | $139.92 | 12,227 | 03 Dec 2024 | Direct | F2 |
| transaction | DORM | Common Stock | Options Exercise | $120,065 | +1,246 | +10% | $96.36 | 13,473 | 03 Dec 2024 | Direct | |
| transaction | DORM | Common Stock | Sale | $159,486 | -1,146 | -8.5% | $139.17 | 12,327 | 03 Dec 2024 | Direct | F3 |
| transaction | DORM | Common Stock | Sale | $14,011 | -100 | -0.81% | $140.11 | 12,227 | 03 Dec 2024 | Direct | |
| transaction | DORM | Common Stock | Options Exercise | $64,079 | +702 | +5.7% | $91.28 | 12,929 | 03 Dec 2024 | Direct | |
| transaction | DORM | Common Stock | Sale | $80,817 | -581 | -4.5% | $139.10 | 12,348 | 03 Dec 2024 | Direct | F4 |
| transaction | DORM | Common Stock | Sale | $16,906 | -121 | -0.98% | $139.72 | 12,227 | 03 Dec 2024 | Direct | F5 |
| transaction | DORM | Common Stock | Sale | $317,147 | -2,280 | -19% | $139.10 | 9,947 | 03 Dec 2024 | Direct | F6 |
| transaction | DORM | Common Stock | Sale | $146,323 | -1,045 | -11% | $140.02 | 8,902 | 03 Dec 2024 | Direct | F7 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DORM | Employee Stock Option (right to buy) | Options Exercise | $0 | -2,912 | -100% | $0.000000 | 0 | 03 Dec 2024 | Common Stock | 2,912 | $61.68 | Direct | F8 |
| transaction | DORM | Employee Stock Option (right to buy) | Options Exercise | $0 | -1,246 | -50% | $0.000000 | 1,246 | 03 Dec 2024 | Common Stock | 1,246 | $96.36 | Direct | F9 |
| transaction | DORM | Employee Stock Option (right to buy) | Options Exercise | $0 | -702 | -25% | $0.000000 | 2,109 | 03 Dec 2024 | Common Stock | 702 | $91.28 | Direct | F10 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.49 to $139.37. The reporting person undertakes to provide to Dorman Products, Inc., any security holder of Dorman Products, Inc. or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.53 to $140.48. The reporting person undertakes to provide to Dorman Products, Inc., any security holder of Dorman Products, Inc. or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.59 to $139.50. The reporting person undertakes to provide to Dorman Products, Inc., any security holder of Dorman Products, Inc. or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.49 to $139.45. The reporting person undertakes to provide to Dorman Products, Inc., any security holder of Dorman Products, Inc. or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.56 to $140.01. The reporting person undertakes to provide to Dorman Products, Inc., any security holder of Dorman Products, Inc. or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.54 to $139.53. The reporting person undertakes to provide to Dorman Products, Inc., any security holder of Dorman Products, Inc. or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.54 to $140.50. The reporting person undertakes to provide to Dorman Products, Inc., any security holder of Dorman Products, Inc. or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F8 | The option vested in four equal annual installments beginning on March 2, 2021, which was the first anniversary of the date of grant. |
| F9 | The option vests in four equal annual installments beginning on March 2, 2023, which is the first anniversary of the date of grant. |
| F10 | The option vests in four equal annual installments beginning on March 2, 2024, which is the first anniversary of the date of grant. |
The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.